Clinical Trial Update: Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating dutogliptin in combination with filgrastim for patients after acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• Dutogliptin (dutogliptin)
• Filgrastim (filgrastim)

Snippet

Sponsor: Recardio, Inc. | Conditions: Acute Myocardial Infarction, Acute Myocardial Ischemia | Phase 2 | Status: COMPLETED